JPH0317825B2 - - Google Patents

Info

Publication number
JPH0317825B2
JPH0317825B2 JP55067963A JP6796380A JPH0317825B2 JP H0317825 B2 JPH0317825 B2 JP H0317825B2 JP 55067963 A JP55067963 A JP 55067963A JP 6796380 A JP6796380 A JP 6796380A JP H0317825 B2 JPH0317825 B2 JP H0317825B2
Authority
JP
Japan
Prior art keywords
magnesium
acetylhomotaurate
calcium
temperature
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP55067963A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5625146A (en
Inventor
Pieeru Deyururashu Jan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RU LAB MERAMU
Original Assignee
RU LAB MERAMU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RU LAB MERAMU filed Critical RU LAB MERAMU
Publication of JPS5625146A publication Critical patent/JPS5625146A/ja
Publication of JPH0317825B2 publication Critical patent/JPH0317825B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C309/13—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
    • C07C309/14—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton containing amino groups bound to the carbon skeleton
    • C07C309/15—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton containing amino groups bound to the carbon skeleton the nitrogen atom of at least one of the amino groups being part of any of the groups, X being a hetero atom, Y being any atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP6796380A 1979-05-23 1980-05-23 33aminopropanesulfonic acid derivative Granted JPS5625146A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7913207A FR2457281A1 (fr) 1979-05-23 1979-05-23 Nouveaux derives de l'acide 3-aminopropanesulfonique ayant une activite membranaire renforcee

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2276598A Division JPH03148219A (ja) 1979-05-23 1990-10-17 膜安定化剤

Publications (2)

Publication Number Publication Date
JPS5625146A JPS5625146A (en) 1981-03-10
JPH0317825B2 true JPH0317825B2 (en]) 1991-03-11

Family

ID=9225819

Family Applications (2)

Application Number Title Priority Date Filing Date
JP6796380A Granted JPS5625146A (en) 1979-05-23 1980-05-23 33aminopropanesulfonic acid derivative
JP2276598A Granted JPH03148219A (ja) 1979-05-23 1990-10-17 膜安定化剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2276598A Granted JPH03148219A (ja) 1979-05-23 1990-10-17 膜安定化剤

Country Status (18)

Country Link
US (1) US4355043A (en])
JP (2) JPS5625146A (en])
AT (1) AT372371B (en])
AU (1) AU535785B2 (en])
BE (1) BE883468A (en])
CA (1) CA1152100A (en])
CH (1) CH647757A5 (en])
DE (2) DE19675017I2 (en])
ES (1) ES8101042A1 (en])
FR (1) FR2457281A1 (en])
GB (1) GB2051789B (en])
GR (1) GR68547B (en])
IT (1) IT1130455B (en])
MA (1) MA18855A1 (en])
MX (1) MX9203363A (en])
NL (2) NL191789C (en])
OA (1) OA06606A (en])
ZA (1) ZA803051B (en])

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU193197B (en) * 1984-02-03 1987-08-28 Egyt Gyogyszervegyeszeti Gyar Preparatives regulating the growth of plants containing as reagent derivatives of n-substituated amin-prophansulphonic acid and process for production of the reagent
JPH0725771B2 (ja) * 1992-06-18 1995-03-22 財団法人生産開発科学研究所 ２−アミノエタンスルホン酸亜鉛錯化合物
US20040208875A1 (en) * 1995-03-15 2004-10-21 Queen's University At Kingston Method for treating amyloidosis
AU703540B2 (en) * 1996-03-26 1999-03-25 Meddiss, Incorporated Methods for inducing analgesia or anesthesia and treating or preventing ischemic injury of tissues in general
US6057373A (en) * 1997-05-22 2000-05-02 Synchroneuron, Llc Methods of treating tardive dyskinesia and other movement disorders using NMDA receptor antagonists
US6294583B1 (en) * 1998-01-13 2001-09-25 Synchroneuron, Llc Methods of treating tardive dyskinesia and other movement disorders
US5952389A (en) * 1998-01-13 1999-09-14 Synchroneuron Methods of treating tardive dyskinesia and other movement disorders
AU765522B2 (en) * 1998-01-13 2003-09-18 Synchroneuron, Llc Methods of treating tardive dyskinesia and other movement disorders
US6391922B1 (en) 1998-01-13 2002-05-21 Synchroneuron, Llc Treatment of posttraumatic stress disorder, obsessive-compulsive disorder and related neuropsychiatric disorders
EP1051393B1 (fr) * 1998-01-27 2003-10-01 Merck Sante Nouveaux derives d'acides aminoalkane sulfoniques, phosphoniques et phosphiniques, leur preparation et leur utilisation comme medicaments
US20020022657A1 (en) * 1998-02-11 2002-02-21 Francine Gervais Methods for modulating neuronal cell death
FR2775188B1 (fr) 1998-02-23 2001-03-09 Lipha Forme galenique a liberation immediate ou liberation prolongee administrable par voie orale comprenant un agent promoteur d'absorption et utilisation de cet agent promoteur d'absorption
DE60042896D1 (de) * 1999-04-28 2009-10-15 Bellus Health Int Ltd Zusammensetzungen und verfahren zur behandlung von amyloidosis mit sulphonatderivaten
US6562836B1 (en) * 1999-05-24 2003-05-13 Queen's University Of Kingston Methods and compounds for inhibiting amyloid deposits
US7244764B2 (en) * 2003-06-23 2007-07-17 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US7414076B2 (en) * 2003-06-23 2008-08-19 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US20070010573A1 (en) 2003-06-23 2007-01-11 Xianqi Kong Methods and compositions for treating amyloid-related diseases
JP2008519822A (ja) * 2004-11-12 2008-06-12 ニューロケム （インターナショナル） リミテッド アミロイド関連疾患を治療するための方法およびフッ素化組成物
JP2008520647A (ja) * 2004-11-16 2008-06-19 ニューロケム （インターナショナル） リミテッド Ｃｎｓおよびアミロイド関連疾患治療のための化合物
BRPI0519243A2 (pt) 2004-12-22 2009-01-06 Neurochem Int Ltd mÉtodos e composiÇÕes para tratar doenÇas relacionadas a amilàide
TW200716088A (en) * 2005-04-15 2007-05-01 Neurochem Int Ltd Formulations and methods for treating amyloidosis
WO2007125385A2 (en) * 2005-12-22 2007-11-08 Neurochem (International) Limited Treatment of renal disorders, diabetic nephopathy and dyslipidemias
AU2007357451B2 (en) 2006-10-12 2012-11-15 Bhi Limited Partnership. Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
WO2008078176A1 (en) * 2006-12-22 2008-07-03 Bellus Health (International) Limited Methods, compounds, and compositions for treating metabolic disorders and diabetes
KR100877134B1 (ko) * 2007-05-03 2009-01-09 주식회사 엔지켐 아캄프로세이트 칼슘의 제조방법
CA2703831C (en) * 2007-09-07 2013-04-16 Xenoport, Inc. Complex pantoic acid ester neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use
US20090082464A1 (en) * 2007-09-07 2009-03-26 Bernd Jandeleit Externally masked neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use
US20090099253A1 (en) * 2007-10-15 2009-04-16 Xenoport, Inc. Internally Masked Neopentyl Sulfonyl Ester Cyclization Release Prodrugs of Acamprosate, Compositions Thereof, and Methods of Use
CN101492400B (zh) * 2008-01-22 2014-03-12 北京华禧联合科技发展有限公司 一种高纯度阿坎酸钙的制备方法
DE102008048791A1 (de) 2008-09-24 2010-03-25 Merck Patent Gmbh Neue Kristallform von Calcium-3-Acetylaminopropan-1-sulfonat
IT1392327B1 (it) * 2008-09-26 2012-02-28 Laboratorio Chimico Int Spa Nuova forma polimorfa del calcio acamprosato
CN104478766A (zh) * 2014-12-25 2015-04-01 北京华禧联合科技发展有限公司 一种制备高纯度乙酰基高牛磺酸的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3039916A (en) * 1961-03-27 1962-06-19 West Laboratories Inc Anionic iodine complexes
US3544597A (en) * 1969-06-12 1970-12-01 Rohm & Haas Process for manufacturing sulfonated amides
JPS5418714B2 (en]) * 1974-10-08 1979-07-10
FR2321285A1 (fr) * 1975-08-18 1977-03-18 Stanley Drug Products Inc Agents antifibrinolytiques
FR2384751A1 (fr) * 1977-03-23 1978-10-20 Francaise Coop Pharma Nouveaux derives de la taurine a activite neuro-musculaire renforcee
US4233229A (en) * 1978-01-03 1980-11-11 Gaf Corporation Preparation of salt-free N-acyl taurines

Also Published As

Publication number Publication date
JPH0524135B2 (en]) 1993-04-06
DE19675017I2 (de) 2001-04-26
CA1152100A (en) 1983-08-16
ES491787A0 (es) 1980-12-16
MX9203363A (es) 1992-07-01
MA18855A1 (fr) 1980-12-31
GB2051789B (en) 1983-04-27
NL191789B (nl) 1996-04-01
IT8067807A0 (it) 1980-05-22
AU535785B2 (en) 1984-04-05
JPS5625146A (en) 1981-03-10
AU5869780A (en) 1980-11-27
ZA803051B (en) 1981-06-24
DE3019350C2 (en]) 1989-11-30
NL970003I2 (nl) 1997-08-01
ES8101042A1 (es) 1980-12-16
NL970003I1 (nl) 1997-04-01
BE883468A (fr) 1980-11-24
CH647757A5 (fr) 1985-02-15
GR68547B (en]) 1982-01-18
DE3019350A1 (de) 1980-12-04
US4355043A (en) 1982-10-19
ATA274580A (de) 1983-02-15
IT1130455B (it) 1986-06-11
NL191789C (nl) 1996-08-02
OA06606A (fr) 1981-08-31
AT372371B (de) 1983-09-26
FR2457281B1 (en]) 1983-10-07
FR2457281A1 (fr) 1980-12-19
NL8002997A (nl) 1980-11-25
JPH03148219A (ja) 1991-06-25
GB2051789A (en) 1981-01-21

Similar Documents

Publication Publication Date Title
JPH0317825B2 (en])
EP2186792B1 (en) 2-(a-hydroxypentyl) benzoate and its preparation and use
JP2636847B2 (ja) ジアセチルライン塩及び関節炎の治療におけるそれらの使用
US5618842A (en) N-acyl derivatives of aminoalcohols with polycarboxylic acids able to modulate mast cells in inflammatory processes having neuroimmunogenic origin
US2835702A (en) Benzene 1, 3 disulfonamides possessing diuretic properties
JPS62181246A (ja) 生体活性ポリペプチド類に対し拮抗活性を有するグルタミン酸類およびアスパラギン酸類の新規酸素化アルキル誘導体およびその製造法
JPS6140268A (ja) イミダゾリン、その付加塩及びその製造方法並びにイミダゾリン又はその付加塩を有効成分とする医薬
JPS5919116B2 (ja) 複素環式化合物の製造法
BG60797B2 (bg) Сол на(1-бензил-1н-индазол-3-ил)оксиоцетна киселина с лизин и метод за получаването й
CH429754A (de) Verfahren zur Herstellung eines neuen Hexapeptids
PT100216B (pt) N-{{4,5-di-hidroxi- e 4,5,8-tri-hidroxi-9,10-di-hidro-9,10-dioxo-2-antracentil} carbonil}-aminoacidos uteis na terapia de afeccoes osteoarticulares, processo para a sua preparacao e composicoes farmaceuticas que os contem
US4372954A (en) Moroxydine phenoxyisobutyrates and method of use
TWI613201B (zh) 新的５型磷酸二酯酶抑制劑及其醫藥應用
US4000265A (en) Method for treating arteriosclerotic and cardiovascular disorders
US4189499A (en) Lysine 4-allyloxy-3-chlorophenylacetate and method of its preparation
CN112876408B (zh) 一类短效双季铵化合物及其制备方法和用途
Ross Some alkylating derivatives of nicotinic acid. Synthesis and antineoplastic activities
JPS631314B2 (en])
JPS5910563A (ja) α−（Ｎ−ピロリル）−フエニル酢酸誘導体およびその製造方法
US4559360A (en) Cysteine derivatives, a process for their preparation, and pharmaceutical compositions which contain them
SU1447283A3 (ru) Способ получени конденсированных производных @ S-триазина
US3520920A (en) Amine salts of nopinic acid
EP2909169A1 (en) Crystalline phase of (3s.3s') 4,4'-disulfanediylbis(3-aminobutane 1 -sulfonic acid) with l-lysine
JPS6119632B2 (en])
US3726879A (en) Certain substituted 2-anilino-nicotinic acid derivatives